The new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences
Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure for your work.
Announcements
Most-Read Article:
CRISPR Knock-in Designer: Automatic Oligonucleotide Design Software to Introduce Point Mutations by Gene Editing Methods
Read Article
Re:GEN Open's first continuous volume is available on topics such as CRISPR, CAR-T cells, antiretroviral therapy, cancer research, and more.
Read Full Volume
The only choice for your next manuscript
The things that matter to you are the things that matter to us: speed, credibility, authority, visibility, and discoverability.
Re:GEN Open is the home for your next manuscript.
Submit Your Manuscript- Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc., publishers to deliver an unprecedented publishing experience
- Fast publishing time with current submission to first decision less than 3 weeks
- Broad audience for your article and international exposure across the leading media platforms in the industry